CDE Exam Review Flashcards

1
Q

Physical activity recommendations for children and adolescents

A

At least 60 minutes of moderate intensity physical activity daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Large doses of aspirin, 4grams/day, can cause?

A

Increased basal and stimulated release of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

States of the Trans-theoretical model of behavior change

A
Precontemplation
Contemplation
Preparation
Action
Maintenance
Termination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Trans-theoretical model of behavior change

Stage 1: PRECONTEMPLATION

A

The individual is not aware of the problem and has no intention of change the health behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Trans-theoretical model of behavior change

Stage 2: CONTEMPLATION

A

The individual is aware of the problem & intends to change the behavior, knows benefits of the behavior change and the drawbacks. Can be a state of ambivalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Trans-theoretical model of behavior change

Stage 3: PREPARATION

A

The individual makes plans to facilitate the health behavior change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Trans-theoretical model of behavior change

Stage 4: ACTION

A

The individual is taking action to change the health behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Trans-theoretical model of behavior change

Stage 5: MAINTENANCE

A

The individual demonstrates the ability to sustain behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stages of CKD

A

5 stages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CKD Stage 1

A

Stage 1 - Kidney damage with normal or elevated GFR

GFR >90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CKD Stage 2

A

Kidney damage with mild decreased in GFR

GFR 60-89

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CKD Stage 3

A

Moderate decreased in GFR
GFR 30-59 - evaluate and treat complications
Metformin is contraindicated
if GFR <45 do not start metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CKD Stage 4

A

Severe decreased in GFR

GFR 15-29 - prepare for kidney replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CKD Stage 5

A

Kidney failure

GFR <15 (or dialysis) Replacement if uremia present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Screening for CKD

A

Type 1: 5 years after diagnosis, annually after that

Type 2: At diagnosis and annually also during pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lipid medication contraindicated in dialysis

A

Statins

17
Q

Diabetes Medications contraindicated in Heart Failure

A

TZDs
Saxagliptin (Onglyza)
metformin
alogliptin (Nesina)

18
Q

Niacin

A

an alternative for statin-intolerant people
SE: Flusing, pruritis, rash, GI
Flushing resolves with use and better tolerated with meals
Minimize flushing by taking asa 30 min prior to niacin

19
Q

Triglyceride management

A

People with high TG need to normalize BG first before adding Omega 3, fibrates or niacin.
May need to start insulin if BG are too high
High TG contribute to increased insulin resistance

20
Q

St John’s Wort

A

Anti-depressive properties

Is thought to lower serum concentrations of other drugs

21
Q

GLP-1

albiglutide

A

albiglutide (Tanzium) does have the same wt loss as other GLP-1s. 0.6 kg compared to 2.2-3kg with others at 6 weeks.
Requires mixing and waiting 15-30 mins prior to injection.

22
Q

ASA recommendations

A

low dose asa is recommended in:
T1 and T2
>50 years old
10 year ASCVD risk >10%

23
Q

Insulin resistance

A

Abdominal fat is more metabolic active and turn over of free fatty acids (FFA)
In the liver FFA contributes to insulin resistance (lipotoxicity).
FFA may be used as a fuel source instead of glucose, they can contribute to hyperglycemia

24
Q

ADA 2016 B/P Guidelines for adults with T2D & HTN

A

<140/90

25
Q

ADA 2016 B/P Guidelines for younger individuals

A

lower targets <130/80 are appropriate considering the potential duration of the disease

26
Q

ADA 2016 B/P Guidelines in pregnancy

A

120/80 - 160/105

Lower targets may impair fetal growth

27
Q

ADA Guidelines for starting basal insulin

A

start basal insulin:

  • 10 units a day
  • 0.1 - 0.2 units/kg/day

Adjust 10-15% or 2-4 units once or twice weekly to reach FBG target

For hypo decrease dose by 4 units or 10-20%

Post meal BG reflects efficacy

28
Q

ADA Guidelines for starting meal insulin

A
start meal insulin at:
- 10% of basal rate
- 0.1 units/kg
- 4 units 
Adjust in 1-2 units increments or by 10-15% of the dose
For hypo decrease by 2-4 units or 10-20%
Fasting BG reflects efficacy